An injectable HIV prevention option for people unable to use tablets
The October 2025 NHS announcement described cabotegravir as an additional prevention option for around 1,000 people unable to take oral PrEP.
Explore offers, read our digital publication and get to know businesses serving NHS households. Healthcare Benefits operates independently of the NHS.
Browse the latest briefings filed under Health and Wellness. There are currently 7 articles in this category.